nelfinavir has been researched along with Addiction, Opioid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, LS; Chu, M; Kritz, S; Madray, C | 1 |
Alvanzo, A; Baker, J; Friedland, G; Jatlow, P; McCance-Katz, EF; Moody, DE; Morse, GD; Pade, P; Rainey, PM; Smith, PF | 1 |
Farber, S; McCance-Katz, EF; O'Connor, A; Selwyn, PA | 1 |
3 other study(ies) available for nelfinavir and Addiction, Opioid
Article | Year |
---|---|
Safety, efficacy, and tolerability of nelfinavir-containing antiretroviral therapy for patients coinfected with HIV and hepatitis C undergoing methadone maintenance.
Topics: Adult; Anti-HIV Agents; Female; Hepatitis C; HIV Infections; Humans; Male; Methadone; Middle Aged; Nelfinavir; Opioid-Related Disorders; Retrospective Studies | 2006 |
Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir.
Topics: Adult; Buprenorphine; Case-Control Studies; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Female; HIV Protease Inhibitors; HIV Seronegativity; Humans; Lopinavir; Male; Narcotic Antagonists; Nelfinavir; Opioid-Related Disorders; Probability; Pyrimidinones; Reference Values; Risk Assessment; Ritonavir | 2006 |
Decrease in methodone levels with nelfinavir mesylate.
Topics: Adult; Comorbidity; HIV Infections; HIV Protease Inhibitors; Humans; Male; Methadone; Nelfinavir; Opioid-Related Disorders | 2000 |